Business Reel: NH Electric Co-op has pilot to charge electric cars
Co-op charging network to grow
PLYMOUTH — New Hampshire Electric Co-op is partnering with a group of its commercial members in a pilot program that is adding up to seven publicly available electric vehicle charging stations to the state’s network.
NHEC said the pilot program will help it to better understand the use of and need for electric vehicle charging stations in its service territory. The number of electric registered in New Hampshire is expected to double in 2013, the nonprofit said, which will create opportunities for the expanded development of a network of charging stations.
NHEC has worked with some of its larger commercial members in the hospitality industry to install EV charging stations this year in North Conway (Red Jacket Mountain View Resort), Woodstock (Woodstock Inn Station), Plymouth (Common Man Inn) and Lincoln (Indian Head Resort). Additional charging stations are planned in Meredith (Church Landing at Mill Falls), and Jackson (Bernerhof Inn).
When fully installed, they will complete a ring of stations that are all within the range limits of most electric vehicle and plug-in hybrid vehicles, NHEC said.
Boston Therapeutics appoints board members and CFO
MANCHESTER — Boston Therapeutics Inc. (OTCQB: BTHE), which develops drugs that address diabetes using complex carbohydrate chemistry, has appointed Conroy Chi-Heng Cheng and S. Colin Neill to its board of directors.
In addition, the company named Anthony D. Squeglia as chief financial officer.
Neill replaces Carl Lueders as chair of the company’s audit committee. Lueders left the board to spend more time with his new business venture. Cheng is director of Advance Pharmaceutical Co., which is headquartered in Hong Kong and has the exclusive right to market and sell the Company’s Sugardown product in China, Hong Kong and Macao. Cheng is also a significant shareholder in the company.
Neill was, most recently, president and chief financial officer of Pharmos Corp., a biopharmaceutical company engaged in the discovery and development of novel therapeutics to treat a range of metabolic and nervous system disorders.
He is a CPA with public accounting experience at Arthur Andersen LLP and Price Waterhouse LLP.
Squeglia will lead the company’s financial activities, including interactions with capital markets, and public and investor relations. From 2007 to 2012, he was the chief financial officer for Galectin Therapeutics and its predecessor company Pro-Pharmaceuticals.
Fischer offered job as Fed vice chairman
JERUSALEM — Former Israeli central bank governor Stanley Fischer has been offered the position of vice chairman of the U.S. Federal Reserve, a source familiar with the matter told Reuters on Wednesday.
“He’s been offered the job” the source, who declined to be named, said. The source added that the process would still require approval by the U.S. Senate.
World-renowned economist Fischer ran the Bank of Israel for eight years until he stepped down in June and was widely credited with guiding Israel through the global economic crisis with minimal damage.